Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 13/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | PTGES | O14684 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12887179 | 1.00 | LIMK1 (0.37) | LIMK1KDM4EALDH1A1LMNATP53 | |
| SCHEMBL14942989 | 0.94 | LIMK1 (0.34) | LIMK1KDM4EALDH1A1LMNATP53 | |
| SCHEMBL14942962 | 0.94 | LIMK1 (0.34) | LIMK1KDM4EALDH1A1LMNATP53 | |
| SCHEMBL12887181 | 0.87 | PTGES (0.37) | LIMK1KDM4EALDH1A1LMNATP53 | |
| SCHEMBL10031364 | 0.85 | CNR2 (0.42) | KDM4EALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL12887176 | 0.85 | CNR2 (0.42) | KDM4EALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL12901806 | 0.79 | ALDH1A1 (0.41) | LIMK1ALDH1A1TSHR | |
| SCHEMBL12901808 | 0.79 | ALDH1A1 (0.41) | LIMK1ALDH1A1TSHR | |
| SCHEMBL18950016 | 0.78 | CNR2 (0.37) | KDM4EALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL14942988 | 0.78 | CNR2 (0.37) | KDM4EALDH1A1LMNATP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8440713-B2 | [1]benzothieno[3,2-B][1]benzothiophene compound and method for producing the same, and organic electronic device using the same | RICOH COMPANY, LTD. (JP) | 2013-05-14 | — | — | US | disclosed |
| US-20110040107-A1 | [1]BENZOTHIENO[3,2-B][1]BENZOTHIOPHENE COMPOUND AND METHOD FOR PRODUCING THE SAME, AND ORGANIC ELECTRONIC DEVICE USING THE SAME | RICOH COMPANY, LTD. (JP) | 2011-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110040107-A1 | [1]BENZOTHIENO[3,2-B][1]BENZOTHIOPHENE COMPOUND AND METHOD FOR PRODUCING THE SAME, AND ORGANIC ELECTRONIC DEVICE USING THE SAME | KYAT1, SULT1E1, SULT1A1 | LIMK1 1457/4885KDM4E 1652/4885ALDH1A1 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.